von Stefanie Simons | Dez 3, 2019
BIO.NRW MEDICA-ForumNovember 18th, 2019 Learn more As part of the BIO.NRW MEDICA-Forum on Monday, 18.11.2019, Prof. Dieter Willbold presented Priavoid’s latest research data during his talk “Do we need anti-prionic compounds to treat Alzheimer’s disease?” News...
von Stefanie Simons | Okt 2, 2019
DGN Kongress - StuttgartSeptember 26th, 2019 Learn more Prof. Dieter Willbold participated at the DGN Kongress in Stuttgart.He gave a talk on the 26th September at 09.10 am.Content: Targeting Alzheimer´s disease with the first anti-prionic compound: PRI-002 proved...
von Dagmar jürgens | Mai 6, 2019
Seed Investment March 28th, 2019 Priavoid obtained seed investment. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize Prof. Willbold´s interview with...
von Dagmar jürgens | Mai 3, 2019
CEOs of Priavoid 21st February 2019: Dr. Antje Willuweit and Dr. Sabine Willbold became CEOs of Priavoid. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize...
von Dagmar jürgens | Mrz 26, 2019
AD/PD 2019 March 26th – 31st, 2019 – Lisbon Learn more 29th March 2019: Dieter Willbold presented PRI-002 on the AD/PD 2019 in Lisbon.For further information please click the learn more button above. News & Events: AAIC 2019 Keystone Symposium Neuro4D...
Neueste Kommentare